MASAC Issues Updated Recommendations

Horizons in Hemophilia, October 2013

Submitted by the National Hemophilia Foundation

The National Hemophilia Foundation’s (NHF) Medical and Scientific Advisory Council (MASAC) recently issued the following updated document, which was adopted by NHF’s Board of Directors on June 13, 2013:

MASAC Document #217: MASAC Recommendations Concerning Products Licensed for the Treatment of Hemophilia and Other Bleeding Disorders (Revised April 2013)

The document includes:

• Recommendations for physicians treating patients with hemophilia A and B, von Willebrand disease, and other congenital bleeding disorders
• Recommendations to manufacturers of coagulation products
• Recommendations to the Food and Drug Administration
   

You can access this document on the NHF webpage at

https://www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=57&contentid=693